|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/31 | |
| C12N 1/21 | |||
| C07K 14/33 | |||
| C07K 16/12 | |||
| C07K 1/22 | |||
| A61K 38/16 | |||
| A61K 39/08 |
| (11) | Number of the document | 1041149 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00105371.9 |
| Date of filing the European patent application | 1995-10-23 | |
| (97) | Date of publication of the European application | 2000-10-04 |
| (45) | Date of publication and mention of the grant of the patent | 2007-07-04 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 329154 | 1994-10-24 | US | |
| 405496 | 1995-03-16 | US | |
| 422711 | 1995-04-14 | US | |
| 480604 | 1995-06-07 | US |
| (72) |
Williams, James A., US
Padhye, Nisha V., US
Thalley, Bruce S., US
Stafford, Douglas C., US
Firca, Joseph R., US
Kink, John A., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine CA 92612,
US
|
| (54) | Vaccine and antitoxin for treatment and prevention of C. difficile disease |
| Vaccine and antitoxin for treatment and prevention of C. difficile disease |